At Aurigene Pharmaceutical Services, we offer solutions for all kinds of synthetic chemistry challenges, leveraging our expertise in synthetic chemistry as well as our thorough understanding of various aspects of drug discovery research. With a combination of 600+ highly skilled scientists and a state-of-the-art infrastructure spanned over two sites at Bangalore and Hyderabad, we can support all your synthetic chemistry needs. The team is well-versed in the synthesis of NCEs at all scales, from milligram quantity for a simple primary in vitro Biology and ADME screening needs, to gram scale synthesis for advanced profiling leading to IND filings.
Our discovery chemistry services encompasses heterocyclic chemistry, focused- libraries, peptides, PROTACs, lipids and oligonucleotides. With 40 modular labs equipped with synthesizers and advanced purification instruments, together with a well-equipped analytical infrastructure, we provide the best-in-class medicinal chemistry services to various biotech, pharmaceutical, agrochemical and specialty chemical companies. We are uniquely poised to be a perfect research partner for all your Drug Discovery needs, with a completely digitalized documentation process and compound management facility, an in-house stock of >50000 chemicals and our expertise in providing secure intellectual property.
Synthetic Chemistry Services
- Design-to-Delivery support across various chemistry platforms
- Milligram-scale to Gram-scale delivery of NCEs
- Expertise in solving complex chemistry challenges
- Experienced in parallel catalyst and ligand screening leading to quick resolution of synthetic bottlenecks
Peptide Services
- One stop solution for end to end (discovery-development-manufacturing) services in peptide space
- Proven track record of running integrated peptide drug discovery programs
- Close to two decades of experience in dealing with complex peptide modifications including peptide conjugation
- Long standing collaboration with leading peptide players
Focused Library Synthesis
- Experienced in generating small to medium-sized custom libraries
- In-house collection of building blocks to support custom libraries
- Parallel purification using Mass-Directed HPLC for high throughput
PROTACs
- A decade of experience working with PROTACs and molecular glues
- Analytical team well-versed in the purification of PRTOACs
- In-house library of Partial PROTACs for quick target engagement
Oligonucleotides
- Experience in synthesizing 10-60-mer oligonucleotides
- Synthesis of ASO, Aptamers and Si-RNAs
- Customized phosphoramidites and post-synthesis modifications
Niche Chemistry Areas
- Photo-redox and Organo-Electrochemistry
- C-H activation chemistry
- C-Si, C-P and C-Se bond-forming reactions
- Carbohydrates and nucleoside chemistries
- Steroids and Lipids
- Labelled compounds and Isotopes
Why Aurigene Pharmaceutical Services?
90% of talent is PG or above
Integration of chemistry to biology and CDMO
State-of-the art facilities and modern infrastructure
Data driven decision making- CADD, informatics, advanced software platforms
50K+ compound inventory management system
Integrated Services
Co-located Teams
20+ Years of legacy
Target identification to commercial manufacturing
Virtual Tour
Hyderabad R and D Center
Bangalore R and D Center
Medicinal Chemistry
Peptide Synthesis
Development and Kilo Lab
Contact Us
Resources
JUNE 28, 2022
Neoantigen Specific T cells For Cancer Immunotherapy
Neoantigen specific T cells for cellular cancer immunotherapy An effective anti-tumor immune response in human is marked by presence of T cells reactive against neoantigens. Neoantigens are HLA-bound unique peptides arise from tumor-specific somatic mutations. Neoantigens are highly immunogenic because they are not present in normal tissues and hence...
Read More
Building successful long-term partnerships with CDMOs from early drug discovery through commercialization
Building successful long-term partnerships with CDMOs from early drug discovery through commercialization Maximizing efficiency in drug research, development, and manufacturing is crucial for turning new innovations into therapeutic and financial benefits. Over the past couple of decades, pharmaceutical companies have increasingly turned to contr...
Read More
Technology meets sustainability - How a complex API development process goes green
We are always looking for ways to enhance the sustainability of our products and services. Our team successfully developed a scalable manufacturing process for the API product of one of our Biotech clients using eco-friendly manufacturing technologies. Read the case study to learn more. ...
Read MoreAlternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug
2023
Scalable alternate end-game strategies for the synthesis of the anti-COVID drug molecule Nirmatrelvir (1,PF-07321332) have been described. The first involves a direct synthesis of 1 via amidation of the carboxylic acid 7 (suitably activated as a mixed anhydride with either pivaloyl chloride or T3P) with the ...
Read More-
Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action.
2021
Mutations in MEK1/2 have been described as a resistance mechanism to BRAF/MEK inhibitor treatment. We report the discovery of a novel ATP-competitive MEK1/2 inhibitor with efficacy in wildtype (WT) and mutant MEK12 models. Starting from a HTS hit, we obtained selective, cellularly active ...
Read More -
Synthesis of Anti-covid Drug Nirmatrelvir Using Flow Chemistry
2021
Synthesis of the anti-covid therapeutic Nirmatrelvir by using flow chemistry to enhance efficiency of amide to nitrile conversion in a functionally and Stereochemically Embellished environment. ...
Read More -
Simple and efficient synthesis of imidazoquinoxalines and spiroquinoxalinones via pictect-spengler reaction using Wang resin, Synthetic Communications
2021
An efficient approach for the synthesis of various imidazoquinoxalines and spiroquinoxalinones has been reported from 2-(1H-imidazol-1-yl) aniline and .. ...
Read More
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.